Results 31 to 40 of about 10,964 (203)

Pseudotumor Cerebri Syndrome and Essential Thrombocythemia: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Pseudotumor cerebri syndrome (PTCS) is characterized by elevated intracranial pressure in the absence of intracranial mass lesions, structural abnormalities, or infectious conditions. Although the exact pathogenesis of PTCS remains largely elusive, it is increasingly recognized as a multifactorial condition.
Chang FT, Chen YY, Lin FY.
europepmc   +2 more sources

Pseudotumor Cerebri and Hemolytic Uremic Syndrome, A Rare Association. [PDF]

open access: yesClin Case Rep
ABSTRACT Hemolytic uremic syndrome can present with central nervous system involvement. Idiopathic intracranial hypertension (IIH) is among the possible neurological manifestations of HUS, and clinicians should remain vigilant for extrarenal complications while treating patients with HUS.
Ali A   +6 more
europepmc   +2 more sources

Cerebrospinal fluid (CSF) and idiopatic intracranial hypertension (IIH): a critical review

open access: yesHeadache Medicine, 2022
Pseudotumor cerebri is a syndrome that results from increased intracranial pressure. The main symptoms are headache, vision disturbances, and pulsatile tinnitus.
Renan Domingues   +4 more
doaj   +1 more source

Pseudotumor Cerebri [PDF]

open access: yesCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1978
SUMMARY:Pseudotumor cerebri is a clinical syndrome in which signs and, sometimes, symptoms of raised intracranial pressure are present hut in which mental and neurological function are unaffected. Therefore, the diagnosis is reached after mass and other structural causes of raised pressure have been excluded.Many causes of pseudotumour have been ...
openaire   +2 more sources

Neuro-Behçet, pseudotumor cerebri and ocular signs: a rare association []

open access: yesGMS Ophthalmology Cases, 2013
[english] Introduction: The central nervous system involvement in Behçet’s disease occurs in 5–30% of cases. The diagnosis of pseudotumor cerebri is even rarer (only 22 cases reported worldwide).
Reis Ferreira, Cidalina   +4 more
doaj   +1 more source

Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Pseudotumor cerebri secondary to all-trans retinoic acid in acute promyelocytic leukemia is a reported but rare complication of the therapy. Most cases improve following the discontinuation of all-trans retinoic acid.
Rasul Fahid T   +4 more
doaj   +1 more source

Pseudotumor cerebral secundário a trombose venosa dural: relato de caso pediátrico Pseudotumor cerebri secondary to dural sinus thrombosis: pediatric case report

open access: yesArquivos de Neuro-Psiquiatria, 2005
O pseudotumor cerebral é uma síndrome neurológica relativamente comum na adolescência. Na maioria dos casos, a etiologia é idiopática, mas pode haver complicações graves, como cegueira, relacionadas com a hipertensão intracraniana.
Adriana Rocha Brito   +6 more
doaj   +1 more source

Previously diagnosed leber's hereditary optic neuropathy with clinical signs of idiopathic intracranial hypertension responsive to acetazolamide therapy

open access: yesJournal of Ophthalmic & Vision Research, 2019
Purpose: To present a case of suspected Leber's hereditary optic neuropathy (LHON) with MRI and OCT findings compatible with pseudotumor cerebri responsive to acetazolamide therapy.
Hamid Sajjadi, Hossein Poorsalman
doaj   +1 more source

Pseudotumor cerebri and oral health: a cross-sectional comparison with healthy individuals

open access: yesInterdisciplinary Neurosurgery
Introduction: This study examined the oral health status of patients with pseudotumor cerebri and compared it with that of healthy individuals. Methods: This was a descriptive-analytical, comparative study conducted in 2025.
Sahar Aminmansour   +4 more
doaj   +1 more source

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure

open access: yesLeukemia Research Reports, 2014
Dual differentiation therapy with arsenic trioxide and tretinoin (all-trans-retinoic acid; ATRA) for the management of low and intermediate risk acute promyelocytic leukemia has recently been recommended by the National Comprehensive Cancer Network. Some
Morgan B. Smith   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy